• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-16-2-3p 通过靶向上颌突间充质细胞中的 PDPK1 抑制细胞增殖、迁移并诱导细胞凋亡。

miR‑16‑2‑3p inhibits cell proliferation and migration and induces apoptosis by targeting PDPK1 in maxillary primordium mesenchymal cells.

机构信息

Department of Burns and Plastic Surgery, Children's Hospital of Nanjing Medical University, Nanjing, Jiangsu 210008, P.R. China.

出版信息

Int J Mol Med. 2019 Mar;43(3):1441-1451. doi: 10.3892/ijmm.2019.4070. Epub 2019 Jan 21.

DOI:10.3892/ijmm.2019.4070
PMID:30664182
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6365086/
Abstract

MicroRNAs (miRNAs) post‑transcriptionally regulate gene expression by targeting the 3' untranslated region (UTR) of target genes, and serve diverse roles in cell proliferation, differentiation and apoptosis. However, the association between miR‑16‑2‑3p and 3‑phosphoinositide‑dependent protein kinase‑1 (PDPK1) in nonsyndromic cleft lip (NSCL) remains unclear. In the present study, a luciferase activity assay indicated that miR‑16‑2‑3p negatively regulated PDPK1 in maxillary primordium mesenchymal cells (MPMCs). In addition, it was confirmed that the expression levels of miR‑16‑2‑3p was markedly increased in cleft lip tissues compared with those in adjacent normal lip tissues. A negative correlation between miR‑16‑2‑3p and PDPK1 in cleft lip tissues was observed. Furthermore, miR‑16‑2‑3p inhibited cell proliferation and migration, and induced apoptosis of MPMCs via repressing PDPK1. Finally, miR‑16‑2‑3p exerted its suppressive role in MPMCs by inhibiting the PDPK1/protein kinase B signaling pathway. These results indicate that miR‑16‑2‑3p may inhibit cell proliferation and migration, and promote apoptosis in MPMCs through repression of PDPK1 and may be a potential target for future clinical prevention and treatment of NSCL.

摘要

微小 RNA(miRNAs)通过靶向靶基因的 3'非翻译区(UTR)对基因表达进行转录后调控,在细胞增殖、分化和凋亡中发挥多种作用。然而,miR-16-2-3p 与非综合征性唇裂(NSCL)中 3-磷酸肌醇依赖性蛋白激酶-1(PDPK1)之间的关联尚不清楚。在本研究中,荧光素酶活性测定表明 miR-16-2-3p 在上颌突间充质细胞(MPMCs)中负调控 PDPK1。此外,还证实与相邻正常唇组织相比,裂唇组织中 miR-16-2-3p 的表达水平显著增加。在裂唇组织中观察到 miR-16-2-3p 与 PDPK1 之间存在负相关。此外,miR-16-2-3p 通过抑制 PDPK1 抑制 MPMCs 的增殖和迁移,并诱导其凋亡。最后,miR-16-2-3p 通过抑制 PDPK1/蛋白激酶 B 信号通路在 MPMCs 中发挥其抑制作用。这些结果表明,miR-16-2-3p 可能通过抑制 PDPK1 抑制 MPMCs 的增殖和迁移,并促进其凋亡,可能成为 NSCL 未来临床预防和治疗的潜在靶点。

相似文献

1
miR‑16‑2‑3p inhibits cell proliferation and migration and induces apoptosis by targeting PDPK1 in maxillary primordium mesenchymal cells.miR-16-2-3p 通过靶向上颌突间充质细胞中的 PDPK1 抑制细胞增殖、迁移并诱导细胞凋亡。
Int J Mol Med. 2019 Mar;43(3):1441-1451. doi: 10.3892/ijmm.2019.4070. Epub 2019 Jan 21.
2
A new and important relationship between miRNA-147a and PDPK1 in radiotherapy.miRNA-147a 与 PDPK1 在放疗中的新的重要关系
J Cell Biochem. 2018 Apr;119(4):3519-3527. doi: 10.1002/jcb.26523. Epub 2018 Jan 11.
3
miR-718 is involved in malignancy of papillary thyroid cancer through repression of PDPK1.微小RNA-718通过抑制3-磷酸磷脂酰肌醇依赖性蛋白激酶1参与甲状腺乳头状癌的恶性进展。
Pathol Res Pract. 2018 Nov;214(11):1787-1793. doi: 10.1016/j.prp.2018.08.022. Epub 2018 Aug 24.
4
MiR-377 inhibits the proliferation of pancreatic cancer by targeting Pim-3.微小RNA-377通过靶向原癌基因激酶3抑制胰腺癌的增殖。
Tumour Biol. 2016 Nov;37(11):14813-14824. doi: 10.1007/s13277-016-5295-4. Epub 2016 Sep 16.
5
Phosphoinositide-dependent protein kinase 1 is a potential novel therapeutic target in mantle cell lymphoma.磷酸肌醇依赖性蛋白激酶1是套细胞淋巴瘤中一个潜在的新型治疗靶点。
Exp Hematol. 2018 Mar;59:72-81.e2. doi: 10.1016/j.exphem.2017.12.006. Epub 2017 Dec 26.
6
The enhancement of combination of berberine and metformin in inhibition of DNMT1 gene expression through interplay of SP1 and PDPK1.小檗碱与二甲双胍通过 SP1 和 PDPK1 的相互作用增强对 DNMT1 基因表达的抑制作用。
J Cell Mol Med. 2018 Jan;22(1):600-612. doi: 10.1111/jcmm.13347. Epub 2017 Aug 25.
7
miR-138-1* regulates aflatoxin B1-induced malignant transformation of BEAS-2B cells by targeting PDK1.miR-138-1* 通过靶向 PDK1 调节黄曲霉毒素 B1 诱导的 BEAS-2B 细胞恶性转化。
Arch Toxicol. 2016 May;90(5):1239-49. doi: 10.1007/s00204-015-1551-4. Epub 2015 Jun 18.
8
Stomatin-Mediated Inhibition of the Akt Signaling Axis Suppresses Tumor Growth.Stomatin 通过抑制 Akt 信号轴抑制肿瘤生长。
Cancer Res. 2021 May 1;81(9):2318-2331. doi: 10.1158/0008-5472.CAN-20-2331. Epub 2021 Mar 23.
9
MicroRNA-217 inhibits cell proliferation, invasion and migration by targeting Tpd52l2 in human pancreatic adenocarcinoma.微小 RNA-217 通过靶向人胰腺腺癌中的 Tpd52l2 抑制细胞增殖、侵袭和迁移。
Oncol Rep. 2017 Dec;38(6):3567-3573. doi: 10.3892/or.2017.6036. Epub 2017 Oct 16.
10
LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway.长链非编码 RNA AB073614 通过 PI3K/AKT 信号通路调节结直肠癌细胞的增殖和转移。
Biomed Pharmacother. 2017 Sep;93:1230-1237. doi: 10.1016/j.biopha.2017.07.024. Epub 2017 Jul 20.

引用本文的文献

1
The role of miR-16 and miR-34a family in the regulation of cancers: A review.miR-16和miR-34a家族在癌症调控中的作用:综述
Heliyon. 2025 Feb 17;11(4):e42733. doi: 10.1016/j.heliyon.2025.e42733. eCollection 2025 Feb 28.
2
MicroRNAs in maxillofacial bone modeling and remodeling: implications for malocclusion development and orthodontic treatment.微小RNA在颌面部骨塑形和重塑中的作用:对错牙合畸形发生及正畸治疗的影响
Front Cell Dev Biol. 2024 Mar 13;12:1355312. doi: 10.3389/fcell.2024.1355312. eCollection 2024.
3
Expansion of plasma MicroRNAs over the first month following human stroke.

本文引用的文献

1
The Akt pathway in oncology therapy and beyond (Review).肿瘤治疗领域中 Akt 通路的研究进展及其相关应用(综述)。
Int J Oncol. 2018 Dec;53(6):2319-2331. doi: 10.3892/ijo.2018.4597. Epub 2018 Oct 16.
2
MicroRNA-375 inhibits the proliferation, migration and invasion of kidney cancer cells by triggering apoptosis and modulation of PDK1 expression.微小 RNA-375 通过触发细胞凋亡和调节 PDK1 表达来抑制肾癌细胞的增殖、迁移和侵袭。
Environ Toxicol Pharmacol. 2018 Sep;62:227-233. doi: 10.1016/j.etap.2018.08.002. Epub 2018 Aug 2.
3
Potent antitumor effect of combination therapy with sub-optimal doses of Akt inhibitors and pomalidomide plus dexamethasone in multiple myeloma.
人卒中后第一个月内血浆 MicroRNAs 的扩增。
J Cereb Blood Flow Metab. 2023 Dec;43(12):2130-2143. doi: 10.1177/0271678X231196982. Epub 2023 Sep 11.
4
Sedentary and Trained Older Men Have Distinct Circulating Exosomal microRNA Profiles at Baseline and in Response to Acute Exercise.久坐不动和经过训练的老年男性在基线时以及对急性运动的反应中具有不同的循环外泌体微小RNA谱。
Front Physiol. 2020 Jun 10;11:605. doi: 10.3389/fphys.2020.00605. eCollection 2020.
在多发性骨髓瘤中,次优剂量的Akt抑制剂与泊马度胺加地塞米松联合治疗具有强大的抗肿瘤作用。
Oncol Lett. 2018 Jun;15(6):9450-9456. doi: 10.3892/ol.2018.8501. Epub 2018 Apr 16.
4
Assessing the association between hypoxia during craniofacial development and oral clefts.评估颅面发育期间的缺氧与腭裂之间的关联。
J Appl Oral Sci. 2018;26:e20170234. doi: 10.1590/1678-7757-2017-0234. Epub 2018 May 21.
5
Discoidin Domain Receptor 2 Signaling Regulates Fibroblast Apoptosis through PDK1/Akt.Discoidin Domain Receptor 2 信号通过 PDK1/Akt 调节成纤维细胞凋亡。
Am J Respir Cell Mol Biol. 2018 Sep;59(3):295-305. doi: 10.1165/rcmb.2017-0419OC.
6
A novel non-coding RNA within an intron of CDH2 and association of its SNP with non-syndromic cleft lip and palate.一个位于 CDH2 内含子中的新型非编码 RNA 及其 SNP 与非综合征性唇腭裂的关联。
Gene. 2018 Jun 5;658:123-128. doi: 10.1016/j.gene.2018.03.017. Epub 2018 Mar 7.
7
MiR-1271 negatively regulates AKT/MTOR signaling and promotes apoptosis via targeting PDK1 in pancreatic cancer.miR-1271 通过靶向 PDK1 负调控 AKT/MTOR 信号通路并促进胰腺癌凋亡。
Eur Rev Med Pharmacol Sci. 2018 Feb;22(3):678-686. doi: 10.26355/eurrev_201802_14293.
8
Mir-138-5p acts as a tumor suppressor by targeting pyruvate dehydrogenase kinase 1 in human retinoblastoma.miR-138-5p 通过靶向人视网膜母细胞瘤中的丙酮酸脱氢酶激酶 1 发挥肿瘤抑制作用。
Eur Rev Med Pharmacol Sci. 2017 Dec;21(24):5624-5629. doi: 10.26355/eurrev_201712_14005.
9
L-Carnitine Attenuates Cardiac Dysfunction by Ischemic Insults Through Akt Signaling Pathway.左旋肉碱通过Akt信号通路减轻缺血性损伤所致的心脏功能障碍。
Toxicol Sci. 2017 Dec 1;160(2):429. doi: 10.1093/toxsci/kfx211.
10
MiR-613 suppressed the laryngeal squamous cell carcinoma progression through regulating PDK1.miR-613 通过调控 PDK1 抑制喉鳞状细胞癌的进展。
J Cell Biochem. 2018 Jul;119(7):5118-5125. doi: 10.1002/jcb.26468. Epub 2018 Apr 6.